SOURCE: Novus Acquisition & Development Corp

October 15, 2014 09:00 ET

Novus MedPlan Passes Major Milestone With First Ever Medical Marijuana Cost Savings Plan

MIAMI, FL--(Marketwired - Oct 15, 2014) - Novus Acquisition & Development Corp (PINKSHEETS: NDEV), wholly owned subsidiary Novus Medical Group, Inc., a service provider of the health and wellness savings plan, "Novus MedPlan," is proud to announce that "Enrollment" has officially begun for patients looking to join the Novus MedPlan network.

"We are ecstatic that open enrollment has finally arrived," said Novus President and CEO Andrea Lopez. "We look forward to serving our newly enrolled members and will continue to align ourselves with new medical marijuana dispensaries and alternative wellness centers throughout approved states."

The Novus MedPlan Program is a revolutionary approach to reducing healthcare costs within the MMJ and wellness industry. Individuals and their families can save money on the cost of healthcare-related products and services that are not covered by standard healthcare programs. Patients' cost-saving plan will be 20% to 50% off for members of Novus MedPlan, which include: doctors consultations, alternative medication and medical marijuana in approved states; all for a low fee of $19.95 per month. All patients have the ability to complete their enrollment online 24 hours a day at www.novusmedicalgroup.com/enrollment.htm

About Novus

Novus Acquisition & Development Corp. ("Novus") provides health insurance and related insurance solutions to the medical marijuana industry in states where legal programs exist and alternative health care clinics. NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense put up for sale, put on the market, vend, deliver, supply, circulate, trade, cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on this press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional.

The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government's enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

Safe Harbor

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information